Antihypertensive treatment guided by genetics: PEARL-HT, the randomized proof-of-concept trial comparing rostafuroxin with losartan

The Pharmacogenomics Journal, Published online: 01 March 2021; doi:10.1038/s41397-021-00214-yAntihypertensive treatment guided by genetics: PEARL-HT, the randomized proof-of-concept trial comparing rostafuroxin with losartan

Source: The Pharmacogenomics Journal - March 1, 2021 Category: Drugs & Pharmacology Authors: Lorena Citterio Giuseppe Bianchi Giuseppe A. Scioli Nicola Glorioso Roberto Bigazzi Daniele Cusi Jan A. Staessen Silvio Cavuto Mara Ferrandi Chiara Lanzani Xiaoyi Li Lit-Fui Lau Chern-En Chiang Tzung-Dau Wang Kang-Ling Wang Patrizia Ferrari Paolo Manunta Source Type: research